New Certificate of Suitability (CEP) of Tiapride hydrochloride

LEBSA recently got the Certificate of Suitability (CEP) -R0-CEP 2018-066-Rev 00- by EDQM of Tiapride hydrochloride (CAS 51012-33-0) to offer the best quality product to our customers at the most affordable price.
Tiapride hydrochloride (CAS 51012-33-0) is an antipsychotic agent manufactured in our unique GMP plant located in Barcelona, Spain.

Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance